– USA, MA – HotSpot Therapeutics, a new biotechnology company targeting nature’s regulatory hotspots to discover and develop first-in-class medicines, today announced the completion of a $45 million Series A financing.…
– USA, MA – AVROBIO, Inc., a clinical-stage biotechnology company developing transformative, life-changing gene therapies for rare diseases and cancer, today announced that it has raised $25 million in a Series A financing co-led by Atlas Venture, Clarus and SV Life Sciences.…
– USA, MA – IFM Therapeutics, a biopharmaceutical company developing a portfolio of first-in-class small molecules targeting the innate immune system, today announced the closing of a $27 million Series A financing led by Atlas Venture and Abingworth, with participation from Novartis.…
– USA, MA – Rodin Therapeutics, a biotechnology company applying insights from epigenetics to develop novel therapeutics for neurological disorders, today announced the appointment of Samantha Singer, Chief Operating Officer of the Broad Institute of MIT and Harvard, as an independent member of the company’s Board of Directors.…
– USA, TN – Overdog, Inc, today announced that it has closed a $1.8 million round of financing, which was co-led by Boston-based Atlas Venture and Chicago Ventures.…
